
### [MONDO:0015497](http://purl.obolibrary.org/obo/MONDO_0015497)
**Label:** Hypoglossia/aglossia

**Subclasses:** [MONDO:0013035](http://purl.obolibrary.org/obo/MONDO_0013035) (orofaciodigital syndrome XI), [MONDO:0015399](http://purl.obolibrary.org/obo/MONDO_0015399) (glossopalatine ankylosis), [MONDO:0015498](http://purl.obolibrary.org/obo/MONDO_0015498) (oromandibular-limb anomalies syndrome), [MONDO:0017139](http://purl.obolibrary.org/obo/MONDO_0017139) (oromandibular-limb hypogenesis syndrome), [MONDO:0009793](http://purl.obolibrary.org/obo/MONDO_0009793) (orofaciodigital syndrome III), [MONDO:0009794](http://purl.obolibrary.org/obo/MONDO_0009794) (orofaciodigital syndrome IV), [MONDO:0015375](http://purl.obolibrary.org/obo/MONDO_0015375) (orofaciodigital syndrome), [MONDO:0009795](http://purl.obolibrary.org/obo/MONDO_0009795) (orofaciodigital syndrome IX), [MONDO:0008267](http://purl.obolibrary.org/obo/MONDO_0008267) (orofaciodigital syndrome V), [MONDO:0012049](http://purl.obolibrary.org/obo/MONDO_0012049) (orofaciodigital syndrome VII), [MONDO:0013896](http://purl.obolibrary.org/obo/MONDO_0013896) (Joubert syndrome 18), [MONDO:0010702](http://purl.obolibrary.org/obo/MONDO_0010702) (orofaciodigital syndrome I), [MONDO:0015367](http://purl.obolibrary.org/obo/MONDO_0015367) (Charlie M syndrome), [MONDO:0015422](http://purl.obolibrary.org/obo/MONDO_0015422) (orofaciodigital syndrome type 13), [MONDO:0015421](http://purl.obolibrary.org/obo/MONDO_0015421) (orofaciodigital syndrome type 12), [MONDO:0013003](http://purl.obolibrary.org/obo/MONDO_0013003) (isolated congenital hypoglossia/aglossia), [MONDO:0010176](http://purl.obolibrary.org/obo/MONDO_0010176) (Joubert syndrome with orofaciodigital defect), [MONDO:0014297](http://purl.obolibrary.org/obo/MONDO_0014297) (Joubert syndrome 22), [MONDO:0009642](http://purl.obolibrary.org/obo/MONDO_0009642) (orofaciodigital syndrome type II), [MONDO:0008137](http://purl.obolibrary.org/obo/MONDO_0008137) (orofaciodigital syndrome X), [MONDO:0010431](http://purl.obolibrary.org/obo/MONDO_0010431) (Joubert syndrome 10), [MONDO:0014413](http://purl.obolibrary.org/obo/MONDO_0014413) (orofaciodigital syndrome type 14), [MONDO:0007073](http://purl.obolibrary.org/obo/MONDO_0007073) (Hypoglossia-hypodactyly syndrome), [MONDO:0010336](http://purl.obolibrary.org/obo/MONDO_0010336) (orofaciodigital syndrome VIII), [MONDO:0014932](http://purl.obolibrary.org/obo/MONDO_0014932) (orofaciodigital syndrome XV), 

**Mapped go classes:** [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development), [GO:0060287](http://purl.obolibrary.org/obo/GO_0060287) (epithelial cilium movement involved in determination of left/right asymmetry), [GO:0061371](http://purl.obolibrary.org/obo/GO_0061371) (determination of heart left/right asymmetry), [GO:0007099](http://purl.obolibrary.org/obo/GO_0007099) (centriole replication), [GO:0030030](http://purl.obolibrary.org/obo/GO_0030030) (cell projection organization), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0035082](http://purl.obolibrary.org/obo/GO_0035082) (axoneme assembly), [GO:0021997](http://purl.obolibrary.org/obo/GO_0021997) (neural plate axis specification), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0008589](http://purl.obolibrary.org/obo/GO_0008589) (regulation of smoothened signaling pathway), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:2000314](http://purl.obolibrary.org/obo/GO_2000314) (negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:1904491](http://purl.obolibrary.org/obo/GO_1904491) (protein localization to ciliary transition zone), [GO:0071539](http://purl.obolibrary.org/obo/GO_0071539) (protein localization to centrosome), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:1905515](http://purl.obolibrary.org/obo/GO_1905515) (non-motile cilium assembly), [GO:0047555](http://purl.obolibrary.org/obo/GO_0047555) (3',5'-cyclic-GMP phosphodiesterase activity), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010501](http://purl.obolibrary.org/obo/GO_0010501) (RNA secondary structure unwinding), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0035869](http://purl.obolibrary.org/obo/GO_0035869) (ciliary transition zone), [GO:0017137](http://purl.obolibrary.org/obo/GO_0017137) (Rab GTPase binding), [GO:0005095](http://purl.obolibrary.org/obo/GO_0005095) (GTPase inhibitor activity), [GO:0034451](http://purl.obolibrary.org/obo/GO_0034451) (centriolar satellite), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0060026](http://purl.obolibrary.org/obo/GO_0060026) (convergent extension), [GO:0061511](http://purl.obolibrary.org/obo/GO_0061511) (centriole elongation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0004004](http://purl.obolibrary.org/obo/GO_0004004) (ATP-dependent RNA helicase activity), [GO:0003279](http://purl.obolibrary.org/obo/GO_0003279) (cardiac septum development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0036064](http://purl.obolibrary.org/obo/GO_0036064) (ciliary basal body), [GO:0010172](http://purl.obolibrary.org/obo/GO_0010172) (embryonic body morphogenesis), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0030162](http://purl.obolibrary.org/obo/GO_0030162) (regulation of proteolysis), [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development), [GO:0043015](http://purl.obolibrary.org/obo/GO_0043015) (gamma-tubulin binding), [GO:0043014](http://purl.obolibrary.org/obo/GO_0043014) (alpha-tubulin binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0007602](http://purl.obolibrary.org/obo/GO_0007602) (phototransduction), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005814](http://purl.obolibrary.org/obo/GO_0005814) (centriole), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.00%
- [GO:0005814](http://purl.obolibrary.org/obo/GO_0005814) (centriole) 52.00%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 52.00%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005454](http://purl.obolibrary.org/obo/GO_0005454) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005453](http://purl.obolibrary.org/obo/GO_0005453) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005430](http://purl.obolibrary.org/obo/GO_0005430) (obsolete synaptic vesicle amine transmembrane transporter activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005429](http://purl.obolibrary.org/obo/GO_0005429) (obsolete chromaffin granule amine transmembrane transporter activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005403](http://purl.obolibrary.org/obo/GO_0005403) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005400](http://purl.obolibrary.org/obo/GO_0005400) (obsolete peroxisomal membrane transporter) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005396](http://purl.obolibrary.org/obo/GO_0005396) (obsolete transmembrane conductance regulator activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005390](http://purl.obolibrary.org/obo/GO_0005390) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005386](http://purl.obolibrary.org/obo/GO_0005386) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005382](http://purl.obolibrary.org/obo/GO_0005382) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%


